Mary Kay Inc. Advocates for Women’s Empowerment, Safe and Dignified Work Environments at International Women’s Forum – TIME’S UP UK Virtual Event
22.7.2020 15:00:00 EEST | Business Wire | Press release
On May 21st, Mary Kay Inc., an advocate for global women’s empowerment and entrepreneurship, joined the International Women's Forum (IWF) Virtual Conference, for a session titled “SAFE SETS: An online panel discussion with TIME’S UP UK.”
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005187/en/
Carolyn Passey, General Manager, Mary Kay United Kingdom & Ireland (Photo: Mary Kay Inc.)
The live session tackled the ever-present issue for women across the globe: sexual harassment and abuse in the workplace. TIME’S UP UK stressed the critical importance of changing the culture to ensure a safe workplace free from harassment and referred to the work being done to define safety for women in film through intimacy guidelines.
The speakers with TIME’S UP UK included:
- Dame Heather Rabbatts, TIME’S UP UK Chair, Managing Director of Cove Pictures; Chair of Soho Theatre and non-executive board member for Arts Alliance.
- Ita O’Brien, the UK’s leading Intimacy Coordinator and founder of Intimacy on Set, her company through which she has been developing best practices regarding intimacy and nudity in film, television and theatre and through which she trains Intimacy Coordinators all over the world.
“TIME’S UP’s efforts will help bring about broader change for women in the workplace – worldwide and across industries,” said Carolyn Passey, General Manager of Mary Kay UK and Ireland. “As one of the world’s leading champions of women’s empowerment, Mary Kay is proud to support, through IWF, women leaders who are standing up to give fellow women a voice, help them embrace their identity and define their own boundaries.”
“What was increasingly apparent throughout the conversation was how #MeToo and TIME’S UP have had a huge and positive influence for changing the way productions work, how they are shifting to better practices in many new ways, and in particular with the new role of the Intimacy Coordinator,” said Dame Heather Rabbatts. “The conversation about safe sets is about how we make the culture shift, one industry after another, until we don’t need to have this conversation ever again.”
“‘Yes’, means yes, ‘no’ means no, and ‘maybe’ means no – we celebrate and embrace the ‘no’,” emphasized Ita O’Brien, when talking of the process during which actors get to voice their comfort level when shooting intimate scenes. The firm founded by O’Brien, Intimacy on Set, has put in place guidelines to provide clear lanes of communication and consent not only between actors, but also everyone else involved in shooting intimate and emotional scenes. “Clear boundaries actually create freedom and help understand what is right for you.”
“This line goes to the heart of the matter, and how we are all learning to express where our boundaries lie, and not being afraid to share them,” concluded Dame Heather Rabbatts. “Having in place some mechanisms to protect yourself is very important, so that we know we can exercise a ‘no’. This should empower us in all the sticky and difficult situations that happen in life, whether personal or professional.”
“It is invigorating to witness the influential work that female thought leaders and advocates have achieved over the past several years for the advancement of women’s safety and security in the workplace. These women, some of the most influential thought leaders in the United Kingdom, are on a mission to champion the next generation of women to become tomorrow’s leaders,” said Marty Wikstrom, Member of IWF U.K. and co-chair of the Cornerstone Conference. “IWF has been advancing women’s leadership and championing equality worldwide since 1974, and Mary Kay has been an advocate of women’s entrepreneurship and leadership since 1963. This session reflects a meeting of the minds, and we are proud to showcase this female-fueled partnership.”
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com.
About International Women’s Forum (IWF) and the Leadership Foundation
IWF is an invitation-only membership organization of more than 7,000 diverse and accomplished women from 33 nations on six continents. IWF advances women’s leadership and champions equality worldwide by connecting accomplished women both globally and locally. Members include Fortune 500 executives, government leaders from the local to sovereign level, international nonprofit leaders, and luminaries from the academy, arts and sciences: www.iwforum.org.
About TIME’S UP UK
TIME’S UP is an organisation that insists on safe, fair and dignified work for women of all kinds. In response to the growing TIME’S UP movement in the US, a group of UK-based women: actors, producers, writers and others from the film, TV and theatre industries catalysed a sister initiative in the UK. For maximum impact it is set up under the TIME’S UP brand and aims to amplify and reinforce the message already promoted in the US.
The UK movement seeks to build on key elements of the solidarity letter released by TIME’S UP and the statement by the activists attending the Globes, which emphasised the need to highlight the connections between the harassment revelations in Hollywood and the wider, systematic nature of harassment and violence against women across all industries, contexts and countries with the recognition that this issue is universal. We seek strength in unity and maximum cooperation. The activist statement also flagged the ways in which the TIME’S UP initiative joins an ever-growing collective of organisations, movements and leaders working to end gender-based violence. The UK work stands absolutely in solidarity with existing movements: TIME’S UP UK is also now a recently formed charity, and as a charity we can only continue the work with support and donations. We all appreciate that we are experiencing unprecedented challenges but as TIME’S UP focusses on safety for all women in the workplace, which now includes the home, we hope you will be able to support us: www.timesupuk.org.
About Intimacy on Set
Founded in 2018, Intimacy on Set provides services to TV, film, & theatre when dealing with intimacy, sexual content, and nudity. Its Founder, UK’s leading Intimacy Coordinator, Ita O’Brien, pioneered the role of the Intimacy Coordinator and since 2014 has been developing best practice Intimacy on Set Guidelines, which have been widely adopted in the industry. Championed by the TIME’S UP movement and others, the firm advocates for safe, fair and dignified work for everyone. O’Brien has worked on numerous high profile productions including Normal People (BBC3/Hulu), Sex Education 1&2 (Netflix), Gangs of London (Sky Atlantic), The Great (Hulu) and I May Destroy You (BBC/HBO), and has been widely covered in the national and international media as the leading spokesperson in this space: www.intimacyonset.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200722005187/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 08:30:00 EEST | Press release
Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivoting its portfolio towards higher‑growth and higher‑margin activities. Four acquisiti
Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 08:30:00 EEST | Press release
Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivoting its portfolio towards higher‑growth and higher‑margin activities. Four acquisiti
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 08:00:00 EEST | Press release
4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlights both the serious burden of knee osteoarthritis and the persistent lack of disease-modifying treatment options. It also reflects the strong scientific rationale supporting the 4P004 development program, including its targeted intra-articular approach and the role of synovitis as a key marker of disease progression. 4P004 is a
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 08:00:00 EEST | Press release
4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlights both the serious burden of knee osteoarthritis and the persistent lack of disease-modifying treatment options. It also reflects the strong scientific rationale supporting the 4P004 development program, including its targeted intra-articular approach and the role of synovitis as a key marker of disease progression. 4P004 is a
LTM Wins Two Google Cloud Partner of the Year Awards for 202622.4.2026 05:30:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, announced today that it has received two Google Cloud Partner of the Year 2026 Awards. LTM is being recognized for its achievements in the Google Cloud ecosystem, helping joint customers to drive high-impact, scalable cloud transformations. LTM won the Google Cloud Partner of the Year Award in the Media & Entertainment category by modernizing a global media company's complex data estate with BigQuery. The transformation improved speed, lowered costs, and provided a scalable foundation, enabling real-time analytics and AI-ready pipelines. This approach offers a repeatable model for data modernization in Media and Entertainment industry. Additionally, LTM was honoured with another Google Cloud Partner of the Year Award for Infrastructure Modernization in North America and the transformation of the ERP landscape for a global leader in healthcare services. This resulted in faster time to market, modern scalable ecosys
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
